BioCentury
ARTICLE | Tools & Techniques

Invitrogen goes Stealth

November 10, 2003 8:00 AM UTC

Invitrogen Corp. hopes to distinguish itself from other suppliers of RNAi technology by providing comprehensive packages that allow researchers to use interfering RNA throughout the discovery process. Through its purchase of Sequitur Inc. last week, IVGN added a next-generation RNAi that it believes answers the need for a molecule that is more stable in cells.

IVGN (Carlsbad, Calif.) has been offering its BLOCK-iT package, consisting of custom synthetic short interfering RNA (siRNA), a Dicer enzyme system, a transfection kit and a transcription kit. But Nicky Zahl, director of emerging businesses, said that "customers needed a better, more stable molecule," than siRNA...